Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 27-Jun-24 4:04 PM View:  | Alnylam Pharmaceuticals Inc. (ALNY) | 25-Jun-24 | Option Exercise | 8,500 | $131.21 | $1,115,280.00 | 101% 8.44K to 16.94K | |
| 27-Jun-24 4:04 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 25-Jun-24 | Planned Option Sale | 8,500 | $240.00 | $2,040,000.00 | (50%) 16.94K to 8.44K | |
| 31-May-24 7:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 29-May-24 | Option Exercise | 30,000 | $66.83 | $2,004,900.00 | 22059% 0.14K to 30.14K | |
| 31-May-24 7:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 29-May-24 | Planned Option Sale | 21,700 | $148.60 | $3,224,550.00 | (72%) 30.14K to 8.44K | |
| 27-Feb-23 4:13 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 23-Feb-23 | Option Exercise | 136 | -- | -- | 100% 0 to 0.14K | |
| 23-Dec-21 5:15 PM View: | Sqz Biotechnologies Co (SQZ) | 22-Dec-21 | Option Exercise | 24,130 | $3.52 | $84,822.80 | < 1% 3.2M to 3.22M | |
| 15-Dec-21 5:15 PM View: | Sqz Biotechnologies Co (SQZ) | 13-Dec-21 | Market Purchase | 3,700 | $10.91 | $40,367.00 | < 1% 3.19M to 3.2M | (8%) |
| 03-Nov-20 8:00 PM View: | Sqz Biotechnologies Co (SQZ) | 03-Nov-20 | Conversion | 22,204 | -- | -- | 13% 168.48K to 190.68K | |
| 03-Nov-20 8:00 PM View: | Sqz Biotechnologies Co (SQZ) | 03-Nov-20 | Conversion | 2,753,510 | -- | -- | 1444% 190.68K to 2.94M | |
| 03-Nov-20 8:00 PM View: | Sqz Biotechnologies Co (SQZ) | 03-Nov-20 | Purchase | 250,000 | $16.00 | $4,000,000.00 | 8% 2.94M to 3.19M | |
| 10-Apr-19 4:13 PM View: | Cyclerion Therapeutics, Inc. (CYCN) | 08-Apr-19 | Market Purchase | 626,117 | $16.00 | $10,017,900.00 | 8339% 7.51K to 633.63K | (80%) |
| 03-Apr-19 6:05 PM View: | Ironwood Pharmaceuticals Inc (IRWD) | 01-Apr-19 | Disposition | 4,056 | -- | -- | (10%) 42.3K to 38.24K | |
| 03-Apr-19 7:34 PM View: | Cyclerion Therapeutics, Inc. (CYCN) | 01-Apr-19 | Grant | 7,508 | -- | -- | 100% 0 to 7.51K | |
| 19-Mar-19 4:06 PM View: | Ironwood Pharmaceuticals Inc (IRWD) | 15-Mar-19 | Grant | 183 | -- | -- | < 1% 42.12K to 42.3K | |
| 18-Dec-18 5:28 PM View: | Ironwood Pharmaceuticals Inc (IRWD) | 14-Dec-18 | Grant | 212 | -- | -- | < 1% 41.9K to 42.12K | |
| 18-Sep-18 4:21 PM View: | Ironwood Pharmaceuticals Inc (IRWD) | 14-Sep-18 | Grant | 136 | -- | -- | < 1% 41.77K to 41.9K | |
| 19-Jun-18 6:43 PM View: | Ironwood Pharmaceuticals Inc (IRWD) | 15-Jun-18 | Grant | 126 | -- | -- | < 1% 41.64K to 41.77K | |
| 04-Jun-18 5:30 PM View: | Ironwood Pharmaceuticals Inc (IRWD) | 31-May-18 | Grant | 16,223 | -- | -- | 64% 25.42K to 41.64K | |
| 24-Apr-18 4:52 PM View: | Blue Buffalo Pet Products, ... (BUFF) | 24-Apr-18 | Disposition | 14,819 | -- | -- | (100%) 14.82K to 0 | |
| 02-Jun-17 5:04 PM View: | Ironwood Pharmaceuticals Inc (IRWD) | 31-May-17 | Grant | 15,625 | -- | -- | 160% 9.79K to 25.42K | |
| 04-Apr-17 4:30 PM View: | Blue Buffalo Pet Products, ... (BUFF) | 31-Mar-17 | Grant | 3,695 | -- | -- | 33% 11.12K to 14.82K | |
| 04-Jan-17 5:08 PM View: | Ironwood Pharmaceuticals Inc (IRWD) | 01-Jan-17 | Grant | 9,793 | -- | -- | 100% 0 to 9.79K | |
| 05-Apr-16 4:11 PM View: | Blue Buffalo Pet Products, ... (BUFF) | 01-Apr-16 | Grant | 3,324 | -- | -- | 43% 7.8K to 11.12K | |
| 16-May-13 8:18 PM View: | Pfizer Inc. (PFE) | 15-May-13 | Market Sale (Planned) | 70,000 | $29.36 | $2,055,390.00 | (24%) 297.0K to 227.0K | (31%) |
| 04-Mar-13 7:53 PM View: | Pfizer Inc. (PFE) | 28-Feb-13 | Grant | 64,373 | -- | -- | 26% 251.45K to 315.82K | |
| 04-Mar-13 7:53 PM View: | Pfizer Inc. (PFE) | 28-Feb-13 | Payment of Exercise | 20,336 | $27.37 | $556,596.00 | (6%) 315.82K to 295.49K | (42%) |
| 08-Feb-13 4:23 PM View: | Zoetis Inc. (ZTS) | 06-Feb-13 | Private Purchase | 5,000 | $26.00 | $130,000.00 | 100% 0 to 5.0K | |
| 07-Dec-12 2:36 PM View: | Pfizer Inc. (PFE) | 06-Dec-12 | Option Exercise | 100,000 | $17.47 | $1,747,000.00 | 40% 249.7K to 349.7K | |
| 07-Dec-12 2:36 PM View: | Pfizer Inc. (PFE) | 06-Dec-12 | Market Option Sale | 100,000 | $25.56 | $2,555,930.00 | (29%) 349.7K to 249.7K | (53%) |
| 27-Feb-12 6:12 PM View: | Pfizer Inc. (PFE) | 24-Feb-12 | Grant | 37,626 | -- | -- | 17% 226.4K to 264.02K | |
| 27-Feb-12 6:12 PM View: | Pfizer Inc. (PFE) | 24-Feb-12 | Payment of Exercise | 18,990 | $21.18 | $402,208.00 | (7%) 264.02K to 245.03K | (84%) |
| 27-Feb-12 6:12 PM View: | Pfizer Inc. (PFE) | 23-Feb-12 | Grant | 32,988 | -- | -- | 17% 193.41K to 226.4K | |
| 05-Jul-11 10:47 AM View: | Pfizer Inc. (PFE) | 30-Jun-11 | Payment of Exercise | 57,864 | $20.60 | $1,192,000.00 | (23%) 246.88K to 189.01K | (95%) |
| 28-Feb-11 9:24 PM View: | Pfizer Inc. (PFE) | 24-Feb-11 | Grant | 51,615 | -- | -- | 27% 192.63K to 244.25K | |
| 01-Mar-10 9:02 PM View: | Pfizer Inc. (PFE) | 25-Feb-10 | Grant | 36,211 | -- | -- | 25% 147.79K to 184.0K | |
| 02-Mar-09 6:26 PM View: | Pfizer Inc. (PFE) | 26-Feb-09 | Grant | 33,911 | -- | -- | 32% 107.51K to 141.42K | |
| 01-Jul-08 2:59 PM View: | Pfizer Inc. (PFE) | 30-Jun-08 | Grant | 100,000 | -- | -- | 7692% 1.3K to 101.3K |